Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
3,685
3,685 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- CBT-004Phase 21 trial
Cloudbreak Therapeutics, LLC · Pinguecula
- CBX-12Phase 21 trial
Cybrexa Therapeutics · Solid Tumor, Adult, Epithelial Ovarian Cancer, Small Cell Lung Carcinoma
- CC-38Phase 21 trial
CuraCell TX AB · Metastatic Colorectal Cancer, Prostate Cancer Metastatic, Prostate Cancer Locally Advanced
- CD19Phase 21 trial
Chongqing Precision Biotech Co., Ltd · B-ALL
- CD25Phase 21 trial
PolTREG S.A. · Presymptomatic Diabetes Type 1 (Stage 1), Diabetes Mellitus, Type I, Diabetes Mellitus, Type 1
- CD38Phase 21 trial
Shandong New Time Pharmaceutical Co., LTD · Relapsed or Refractory Multiple Myeloma
- CDI-988Phase 21 trial
Cocrystal Pharma, Inc. · Norovirus
- CEB-01Phase 21 trial
CEBIOTEX · Locally Resectable Pediatrics Tumors
- CELZ-201-DDTPhase 21 trial
Creative Medical Technology Holdings Inc · Chronic Low-back Pain, Degenerative Disc Disease
- certepetideCEND-1, LSTA1Phase 21 trial
Lisata Therapeutics, Inc. · Cholangiocarcinoma, Gallbladder Cancer, Gallbladder Carcinoma
- CFI-400945Phase 21 trial
Treadwell Therapeutics, Inc · Acute Myeloid Leukemia, Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia
- CFI-402257Phase 21 trial
Treadwell Therapeutics, Inc · Advanced Solid Tumor, Breast Cancer
- CGT4859Phase 21 trial
Cogent Biosciences, Inc. · Intrahepatic Cholangiocarcinoma (Icc), Cholangiocarcinoma, Other Solid Tumors, Adult
- CHF 6001Phase 21 trial
Chiesi Farmaceutici S.p.A. · Asthma
- CHF10067Phase 21 trial
Chiesi Farmaceutici S.p.A. · Idiopathic Pulmonary Fibrosis
- CHF6333Phase 21 trial
Chiesi Farmaceutici S.p.A. · Bronchiectasis
- CJRB-101Phase 21 trial
CJ Bioscience, Inc. · NSCLC, HNSCC, Melanoma
- CK0801Phase 21 trial
Cellenkos, Inc. · Aplastic Anemia
- CK0802Allogeneic, Cryopreserved, Cord blood-derived T-regulatory cells, cells that are not HLA matchedPhase 21 trial
Cellenkos, Inc. · Steroid Refractory Graft Versus Host Disease
- CKD-703Phase 21 trial
Chong Kun Dang Pharmaceutical · Advanced Solid Tumors, Non-Small Cell Lung Cancer
- CL-197Phase 21 trial
Henan Genuine Biotech Co., Ltd. · HIV-1 Infection
- CLE-100Phase 21 trial
Clexio Biosciences Ltd. · Adjunctive Treatment of Major Depressive Disorder (MDD)
- CLIO-8221Phase 21 trial
Callio Therapeutics · Advanced Solid Tumor
- CLN-049Phase 21 trial
Cullinan Therapeutics Inc. · Relapsed/Refractory Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), TP53-mutated MDS and AML
- CM338Phase 21 trial
Keymed Biosciences Co.Ltd · IgA Nephropathy
- CM355Phase 21 trial
Beijing InnoCare Pharma Tech Co., Ltd. · Hematoma
- CM518D1Phase 21 trial
Keymed Biosciences Co.Ltd · Advanced Solid Tumors
- CM529D1Phase 21 trial
Keymed Biosciences Co.Ltd · Advanced Solid Tumors
- CMND-100MEAIPhase 21 trial
Clearmind Medicine Inc. · Alcohol Use Disorder
- CMP-002Phase 21 trial
CAMP4 Therapeutics Corporation · Nervous System Disease
- CMTX-101Phase 21 trial
Clarametyx Biosciences, Inc. · Persistent Infection, Cystic Fibrosis
- CNP-103Phase 21 trial
COUR Pharmaceutical Development Company, Inc. · Type 1 Diabetes Mellitus, T1D, T1DM
- CNP-104Phase 21 trial
COUR Pharmaceutical Development Company, Inc. · Primary Biliary Cholangitis
- CNP-106Phase 21 trial
COUR Pharmaceutical Development Company, Inc. · Myasthenia Gravis, Generalized Myasthenia, AChR Myasthenia Gravis
- coformulation pembrolizumabPhase 21 trial
Merck & Co. · Small Cell Lung Carcinoma
- COL-5671-PROPhase 21 trial
Coultreon Biopharma · Plaque Psoriasis
- COM701Phase 21 trial
Compugen Ltd · Ovarian Cancer, Ovarian Cancer Recurrent
- Combination of NavepegritidePhase 21 trial
Ascendis Pharma Growth Disorders A/S · Achondroplasia
- COR-1167Phase 21 trial
Corteria Pharmaceuticals · Worsening Heart Failure
- CORT113176DazucorilantPhase 21 trial
Corcept Therapeutics · Amyotrophic Lateral Sclerosis
- CORT125236NenocorilantPhase 21 trial
Corcept Therapeutics · Neoplasms
- CP-383Phase 21 trial
Tasca Therapeutics · Solid Tumor Malignancies, Colorectal Carcinoma, Small Cell Lung Cancer ( SCLC )
- CPK850Phase 21 trial
Novartis · Retinitis Pigmentosa
- CPL500036Phase 21 trial
Celon Pharma SA · Parkinson Disease, Dyskinesia, Medication-Induced
- CPT-11Phase 21 trial
Zhejiang Doer Biologics Co., Ltd. · Gastrointestinal Cancer
- CPX101Phase 21 trial
Guangzhou Chia Tai Innovative Pharmaceutical Co., Ltd. · Overweight and Obesity
- CR-001Phase 21 trial
Crescent Biopharma, Inc. · Locally Advanced / Metastatic Solid Tumors
- CR-002Phase 21 trial
Crescent Biopharma, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M), Gastric/GEJ, Biliary Tract Cancer (BTC)
- CR6086vorbipiprantPhase 21 trial
Rottapharm Biotech · Refractory Metastatic Colorectal Cancer, Solid Tumor, Metastatic Microsatellite-stable Colorectal Cancer
- CRG-150Phase 21 trial
CoRegen, Inc. · HR-positive, HER2-negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, Prostate Cancer
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.